EIR Biopharma, Inc.

Biological Products, (No Diagnostic Substances)

ipo filed S-1

Filing Timeline

SEC EDGAR

S-1 filed

Initial registration statement

Initial public filing submitted to start the SEC review process.

First tracked pre-IPO filing for this issuer.

The filing appears to be a placeholder or incomplete data extract with no substantive narrative content. The document contains technical metadata, financial line items, and references to investors and licensing agreements but lacks a coherent description of the company's business, offerings, or IPO details.

2026-02-17 · 0001520138-26-000057